HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Imai Selected Research

ATX S10Na(II)

9/2007A possible relationship between the anti-cancer potency of photodynamic therapy using the novel photosensitizer ATX-s10-Na(II) and expression of the vascular endothelial growth factor in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Imai Research Topics

Disease

52Neoplasms (Cancer)
07/2020 - 01/2000
17Carcinoma (Carcinomatosis)
04/2016 - 01/2000
16Neoplasm Metastasis (Metastasis)
10/2019 - 05/2000
8Colorectal Neoplasms (Colorectal Cancer)
10/2009 - 03/2001
8Stomach Neoplasms (Stomach Cancer)
07/2007 - 09/2000
8Adenocarcinoma
12/2001 - 01/2000
7Colonic Neoplasms (Colon Cancer)
07/2020 - 07/2001
7Inflammation (Inflammations)
01/2015 - 01/2000
7Carcinogenesis
03/2008 - 01/2000
5Infections
01/2010 - 05/2000
5Lymphatic Metastasis
09/2001 - 04/2001
5Lymphoid Leukemia
05/2001 - 07/2000
4Breast Neoplasms (Breast Cancer)
03/2008 - 02/2001
4Lung Neoplasms (Lung Cancer)
11/2007 - 04/2001
4Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2007 - 07/2001
4Mikulicz' Disease
09/2006 - 01/2004
4Adenoma (Adenomas)
04/2005 - 09/2001
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 05/2012
3Pain (Aches)
01/2014 - 06/2000
3Liver Diseases (Liver Disease)
10/2012 - 07/2001
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2011 - 02/2001
3Respiratory Insufficiency (Respiratory Failure)
01/2010 - 08/2000
3Influenza in Birds (Avian Flu)
11/2009 - 04/2007
3Necrosis
07/2006 - 07/2000
3Fever (Fevers)
07/2005 - 12/2000
3Hepatocellular Carcinoma (Hepatoma)
06/2001 - 03/2000
2Periapical Granuloma
04/2020 - 12/2018
2Death (Near-Death Experience)
05/2016 - 05/2016
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2014 - 03/2006
2Philadelphia Chromosome
06/2013 - 05/2012
2Ischemic Stroke
04/2011 - 08/2006
2Primary Immunodeficiency Diseases
01/2010 - 03/2006
2Fibrosis (Cirrhosis)
08/2009 - 03/2001
2Arthralgia (Joint Pain)
08/2009 - 12/2000
2Seizures (Absence Seizure)
02/2008 - 04/2001
2Hypoxia (Hypoxemia)
09/2007 - 03/2005
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
07/2007 - 03/2001
2Aneurysm (Aneurysms)
01/2006 - 10/2001
2Hypothalamic hamartomas
06/2005 - 08/2003
2Ulcerative Colitis
05/2005 - 01/2001
2Pulmonary Emphysema
02/2005 - 03/2001
2Infantile Spasms (West Syndrome)
10/2003 - 05/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2003 - 04/2001

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
11/2012 - 03/2000
10AntigensIBA
04/2016 - 01/2000
7DNA (Deoxyribonucleic Acid)IBA
04/2020 - 03/2000
7Matrix Metalloproteinases (MMPs)IBA
07/2006 - 02/2001
6beta CateninIBA
03/2008 - 03/2001
6MucinsIBA
12/2001 - 01/2000
5Messenger RNA (mRNA)IBA
04/2020 - 02/2001
5Complementary DNA (cDNA)IBA
01/2011 - 09/2001
5AntibodiesIBA
11/2009 - 05/2000
5Immunoglobulin G (IgG)IBA
08/2009 - 02/2000
5Matrix Metalloproteinase 7 (Matrilysin)IBA
12/2005 - 02/2001
5Monoclonal AntibodiesIBA
12/2001 - 01/2000
4Pharmaceutical PreparationsIBA
07/2020 - 03/2001
4Peptides (Polypeptides)IBA
01/2011 - 05/2000
4Immunoglobulin M (IgM)IBA
07/2010 - 12/2001
4Sulindac (Copal)FDA LinkGeneric
01/2007 - 01/2000
4TeaIBA
09/2001 - 01/2000
3Indicators and Reagents (Reagents)IBA
05/2014 - 05/2000
3EpitopesIBA
01/2011 - 12/2001
3Small Interfering RNA (siRNA)IBA
10/2009 - 07/2006
3LigandsIBA
03/2008 - 12/2001
3CytokinesIBA
02/2008 - 01/2000
3Therapeutic UsesIBA
07/2006 - 09/2000
3SodiumIBA
07/2006 - 03/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2006 - 01/2000
3Biomarkers (Surrogate Marker)IBA
12/2005 - 09/2001
3SteroidsIBA
10/2005 - 06/2000
3Anti-Bacterial Agents (Antibiotics)IBA
07/2005 - 06/2000
3Peptide Hydrolases (Proteases)FDA Link
02/2005 - 03/2001
3Glycoproteins (Glycoprotein)IBA
09/2001 - 07/2001
3EnzymesIBA
07/2001 - 08/2000
3Mucin-1 (CA 15-3 Antigen)IBA
01/2001 - 11/2000
2Tyrosine Kinase InhibitorsIBA
01/2017 - 01/2016
2dicarboxydine (DCD)IBA
05/2016 - 05/2016
2CollagenIBA
04/2016 - 10/2002
2LipopolysaccharidesIBA
01/2015 - 05/2000
2Epidermal Growth Factor (EGF)IBA
07/2013 - 02/2006
2Complement System Proteins (Complement)IBA
07/2010 - 05/2000
2Blood Glucose (Blood Sugar)IBA
07/2010 - 06/2000
2AutoantibodiesIBA
07/2010 - 10/2003
2AntioxidantsIBA
06/2009 - 06/2001
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2008 - 09/2007
21-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2008 - 09/2007
2Histones (Histone)IBA
10/2007 - 06/2002
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
05/2005 - 02/2001
2GlucocorticoidsIBA
02/2005 - 12/2000
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
04/2004 - 02/2001

Therapy/Procedure

14Therapeutics
01/2018 - 09/2000
7Drug Therapy (Chemotherapy)
10/2019 - 08/2002
4Hepatectomy
04/2017 - 04/2016
3Radiofrequency Ablation
04/2017 - 08/2003
2Adjuvant Chemotherapy
10/2019 - 09/2016
2Cell Transplantation
01/2016 - 06/2013
2Stem Cell Transplantation
06/2013 - 06/2004
2Hematopoietic Stem Cell Transplantation
05/2012 - 03/2006
2Immunotherapy
01/2011 - 12/2001
2Photochemotherapy (Photodynamic Therapy)
02/2008 - 09/2007